“CLINICAL STUDY PHASE 1/2 FOR ASSESSING THE SAFETY AND EFFECTIVENESS OF THE CELLULAR PRODUCT HC016 IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS CAUSED BY COVID-19”

Call identifier: COVID-19

Reference Nº: CO-2020/00003

Project financed by the Department of Economic Development and Infrastructures of the Basque Government.

“Research on additive manufacturing solutions of biomaterials for biomedical products”

Call identifier: HAZITEK ESTRATEGICO 2020

Reference Nº: ZE-2020/00021

Project co-financed by the Basque Government and FEDER Funds, under the HAZITEK Business R & D Support program.

“A COMBINED ATMP STRATEGY TO SUPPLEMENT CRITICAL SIZED BONE FRACTURE HEALING”

Grant Agreement: 874889

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874889

Reference Nº: ZE-2019/00012

Project co-financed by the Basque Government and FEDER Funds, under the HAZITEK Business R&D Support program.

The consortium of participating companies in the IMABI project is led by AJL OPHTHALMIC. Its general objective is to research and develop new materials and biofunctional devices through smart specialization, in pursuit of improving the competitiveness of the Basque industrial fabric in the biomedical sector. Likewise, it seeks to respond to the value chain of advanced biofunctional medical devices in this environment.

“FAB117-HC, NEW ALLOGENIC CELLULAR MEDICINE FOR THE TREATMENT OF PATIENTS WITH ACUTE TRAUMATIC SPINAL INJURY: REGULATORY STUDY PHASE I / II”

Call identifier: Proyectos de I+D en Cooperación Nacional

Reference Nº: IDI-20151267

Subsidised by the Center for Industrial Technological Development (CDTI), within the framework of the call 'Research Project and Development in Cooperation'.